Portfolio (Quarterly)
Guide ↗
Soleus Capital Management, L.P.
· CIK 0001802630| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | BDSX | BIODESIX INC | Healthcare | 585,958.0 | $13.2M | 0.46% | +169K | +40.6% | $22.55 | +35.7% |
| 22 | IMVT | IMMUNOVANT INC | Healthcare | 252,000.0 | $9.7M | 0.34% | +22K | +9.6% | $38.53 | +13.9% |
| 23 | INSM | INSMED INC | Healthcare | 90,250.0 | $9.6M | 0.33% | +80K | +780.5% | $106.62 | +16.7% |
| 24 | GPCR | STRUCTURE THERAPEUTICS INC | Healthcare | 107,000.0 | $5.7M | 0.20% | +27K | +33.8% | $53.67 | -8.0% |
| 25 | CNTX | CONTEXT THERAPEUTICS INC | Healthcare | 7,063,141.0 | $3.9M | 0.14% | +100K | +1.4% | $0.55 | -23.5% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%